| SC 13G | 2019-02-13 | STATE STREET CORP | Intellia Therapeutics, Inc. | - | 5.3% | EDGAR |
| SC 13G | 2019-02-11 | VANGUARD GROUP INC | Intellia Therapeutics, Inc. | 2,746,126 | 6.3% | EDGAR |
| SC 13G/A | 2019-02-08 | Atlas Venture Fund IX, L.P. | Intellia Therapeutics, Inc. | 1,615,321 | 3.7% | EDGAR |
| SC 13G | 2019-02-08 | BlackRock Inc. | Intellia Therapeutics, Inc. | 2,868,738 | 6.6% | EDGAR |
| SC 13G/A | 2019-01-16 | Caribou Biosciences, Inc. | Intellia Therapeutics, Inc. | 2,507,245 | 5.8% | EDGAR |
| SC 13D/A | 2018-03-23 | Novartis Institutes for BioMedical Research, Inc. | Intellia Therapeutics, Inc. | 4,277,073 | 10.1% | EDGAR |
| SC 13D/A | 2018-02-16 | ORBIMED ADVISORS LLC | Intellia Therapeutics, Inc. | 2,113,000 | 5.0% | EDGAR |
| SC 13G/A | 2018-02-13 | FMR LLC | Intellia Therapeutics, Inc. | 4,286,577 | 10.1% | EDGAR |
| SC 13G/A | 2018-02-12 | Atlas Venture Fund IX, L.P. | Intellia Therapeutics, Inc. | 3,579,788 | 8.4% | EDGAR |
| SC 13G/A | 2018-02-06 | Caribou Biosciences, Inc. | Intellia Therapeutics, Inc. | 4,545,000 | 10.7% | EDGAR |
| SC 13D/A | 2018-01-29 | ORBIMED ADVISORS LLC | Intellia Therapeutics, Inc. | 2,537,684 | 6.0% | EDGAR |
| SC 13D/A | 2017-12-14 | Novartis Institutes for BioMedical Research, Inc. | Intellia Therapeutics, Inc. | 4,129,903 | 11.4% | EDGAR |
| SC 13D/A | 2017-11-08 | ORBIMED ADVISORS LLC | Intellia Therapeutics, Inc. | 2,537,684 | 6.0% | EDGAR |
| SC 13G | 2017-02-28 | Caribou Biosciences, Inc. | Intellia Therapeutics, Inc. | 5,593,846 | 15.5% | EDGAR |
| SC 13G/A | 2017-02-14 | FMR LLC | Intellia Therapeutics, Inc. | 4,765,481 | 13.2% | EDGAR |
| SC 13G | 2017-02-09 | Atlas Venture Fund IX, L.P. | Intellia Therapeutics, Inc. | 4,429,788 | 12.3% | EDGAR |
| SC 13G | 2016-06-10 | FMR LLC | Intellia Therapeutics, Inc. | 3,885,908 | 10.8% | EDGAR |
| SC 13D | 2016-05-20 | ORBIMED ADVISORS LLC | Intellia Therapeutics, Inc. | 2,662,180 | 7.4% | EDGAR |
| SC 13D | 2016-05-11 | Novartis Institutes for BioMedical Research, Inc. | Intellia Therapeutics, Inc. | 5,573,658 | 15.5% | EDGAR |
| SC 13G | 2016-05-11 | REGENERON PHARMACEUTICALS INC | Intellia Therapeutics, Inc. | 2,777,777 | 7.7% | EDGAR |